Altavo raised €3M in a Series A round announced on January 23, 2026. Giving voiceless people an individual, natural sounding voice.
Giving voiceless people an individual, natural sounding voice.
Altavo, based in Dresden, Germany, announced €3M in Series A financing on January 23, 2026.
Participants include bm-t Beteiligungsmanagement Thüringen GmbH, TGFS Technologiegründerfonds Sachsen, High-Tech Gründerfonds, TUDAG TU Dresden AG, Novalis Biotech, Ostwerk GmbH.
Oviva provides personalized dietary advice combined with digital tools to help individuals change their habits and improve their health.
German company is a provider of targeted drug rescue program intended to involve pharmaceutical research and development.
Biotech company that offers robotic automation solutions to life sciences labs.